Dexmedetomidine and Outcomes of Cardiac Surgery (DOCS)

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1100 participants.

Also called NCT02237495

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 2/3
Enrolled
  • 1,100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02237495
Other papers using this trial's data
  • Effects of Dexmedetomidine on Outcomes After Cardiac Surgery (DOCS): a randomised double-blind, placebo-controlled trial British journal of anaesthesia, 2026-01 DOI, PubMed 41238464

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02237495. Randomized; double masking; primary purpose prevention. Start 2014-04-09 (actual); primary completion 2017-03-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Dexmedetomidine and Outcomes of Cardiac Surgery (DOCS)
Acronym
DOCS
Condition
Heart Valve Diseases
Intervention (Drug)
dexmedetomidine
Intervention (Drug)
placebo
Lead sponsor
Xijing Hospital (class: other)

Record details

Record id
cardio:ct-nct02237495
Content hash
ea0883adaa4f1ac9002ed2a6c6e04a6c2aedefc6e1eb51e248c1541200bb6dc6